INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 202 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q2 2020. The put-call ratio across all filers is 1.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,302,917 | -31.4% | 70,276 | -59.1% | 0.00% | -40.0% |
| Q2 2023 | $1,899,555 | +37.7% | 171,750 | +67.2% | 0.01% | +66.7% |
| Q1 2023 | $1,379,879 | +9798.0% | 102,746 | +9016.8% | 0.00% | – |
| Q4 2022 | $13,941 | +1294.1% | 1,127 | +1510.0% | 0.00% | – |
| Q3 2022 | $1,000 | -99.9% | 70 | -99.9% | 0.00% | -100.0% |
| Q4 2021 | $915,000 | +91400.0% | 56,198 | +5619700.0% | 0.00% | – |
| Q1 2020 | $1,000 | -100.0% | 1 | -100.0% | 0.00% | -100.0% |
| Q4 2019 | $12,018,000 | +15307.7% | 96,984 | +9826.7% | 0.03% | – |
| Q2 2019 | $78,000 | -99.5% | 977 | -99.3% | 0.00% | -100.0% |
| Q1 2019 | $15,724,000 | +599.5% | 140,565 | +530.3% | 0.04% | +550.0% |
| Q4 2018 | $2,248,000 | -79.1% | 22,301 | -73.8% | 0.01% | -76.0% |
| Q3 2018 | $10,744,000 | +1791.5% | 85,025 | +1156.8% | 0.02% | +1150.0% |
| Q2 2018 | $568,000 | +60.9% | 6,765 | +17.9% | 0.00% | +100.0% |
| Q1 2018 | $353,000 | +720.9% | 5,740 | +684.2% | 0.00% | – |
| Q4 2017 | $43,000 | 0.0% | 732 | -2.3% | 0.00% | – |
| Q3 2017 | $43,000 | -41.9% | 749 | +22.6% | 0.00% | – |
| Q2 2017 | $74,000 | -81.7% | 611 | -82.9% | 0.00% | -100.0% |
| Q1 2017 | $404,000 | +39.8% | 3,570 | +34.4% | 0.00% | 0.0% |
| Q4 2016 | $289,000 | -43.8% | 2,656 | -14.9% | 0.00% | 0.0% |
| Q3 2016 | $514,000 | -92.5% | 3,122 | -96.9% | 0.00% | -95.8% |
| Q4 2013 | $6,842,000 | -1.1% | 100,200 | 0.0% | 0.02% | -11.1% |
| Q3 2013 | $6,916,000 | +54.2% | 100,200 | +0.2% | 0.03% | +50.0% |
| Q2 2013 | $4,484,000 | – | 100,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 635,300 | $53,308,000 | 10.69% |
| Senvest Management, LLC | 976,127 | $81,907,000 | 5.65% |
| Melqart Asset Management (UK) Ltd | 390,600 | $32,775,000 | 2.80% |
| Asymmetry Capital Management, L.P. | 25,918 | $2,175,000 | 2.14% |
| Elk Creek Partners, LLC | 386,397 | $32,423,000 | 1.78% |
| BB BIOTECH AG | 545,719 | $45,791,000 | 1.32% |
| ALTRINSIC GLOBAL ADVISORS LLC | 383,166 | $32,151,000 | 1.27% |
| DLD Asset Management, LP | 129,000 | $10,824,000 | 0.82% |
| Opus Point Partners Management, LLC | 3,998 | $335,000 | 0.73% |
| Virtus ETF Advisers LLC | 8,970 | $753,000 | 0.67% |